Vivo Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Vivo Capital’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-483,413	Closed	-$8.67M	–	52
2022 Q3	$8.67M	Sell	483,413 -4,755,221	-91%	-$62.4M	0.96%	29
2022 Q2	$50.4M	Sell	5,238,634 -1,193,306	-19%	-$15M	5.06%	4
2022 Q1	$108M	Buy	6,431,940 +141,113	+2%	+$2.09M	7.45%	4
2021 Q4	$105M	Buy	6,290,827 +324,300	+5%	+$5.32M	6.34%	4
2021 Q3	$96.9M	Hold	5,966,527	–	–	4.35%	7
2021 Q2	$37.6M	Hold	5,966,527	–	–	1.63%	15
2021 Q1	$36.9M	Hold	5,966,527	–	–	1.3%	18
2020 Q4	$41.2M	Hold	5,966,527	–	–	1.84%	11
2020 Q3	$33.7M	Hold	5,966,527	–	–	1.94%	11
2020 Q2	$30.4M	Buy	+5,966,527	New	+$24.9M	2.18%	10

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vivo Capital's ISEE Position: Q4 2022 in Review

Vivo Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2022, closing a stake of 483,413 shares — an estimated $8.67M sold.

Vivo Capital first reported a position in ISEE in Q2 2020 and held it in 10 quarters. The position peaked at $108M in Q1 2022. 225 funds tracked by Wall St. Rank hold ISEE as of Q4 2022.

Vivo Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Vivo Capital sold 483,413 IVERIC bio, Inc. Common Stock shares in Q4 2022, an estimated $8.67M.
Vivo Capital first reported a position in IVERIC bio, Inc. Common Stock in Q2 2020 and held it in 10 quarters.
Vivo Capital's IVERIC bio, Inc. Common Stock position peaked at $108M in Q1 2022.
225 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2022.

Based on Vivo Capital's 13F filing for Q4 2022, filed 13 Feb 2023.